07 Feb 2020 --- A new collaboration between Danone Nutricia Research and the University of California, San Diego’s Microsetta Initiative is recruiting hundreds of US citizens to map their gut microbiomes. The project offers participants an opportunity to get their microbiome sequenced and tested, free of personal charge. In the same gut-health related space, microbiome restoration therapy company MaaT Pharma has announced an €18 million (US$19.7 million) Series B financing round including a microbiome-focused US investor, SymBiosis.
